May 21st, 2014
The Risk-Prediction Conundrum: Individual Risk vs. Population Risk
John W McEvoy, MB BCh BAO
John W. McEvoy discusses his recent review article about how to interpret cardiac risk for an individual patient when risk estimates are more accurate for populations of patients.
July 26th, 2012
ESC Position Paper: Population-Based Strategies to Reduce CV Deaths
Larry Husten, PHD
About half of all cardiovascular deaths could be prevented by implementing population-level changes, according to a position paper from the European Society of Cardiology published in the European Journal of Preventive Cardiology. Torben Jørgensen and colleagues maintain that population-level interventions are much more effective than current strategies that seek to reduce individual risk. Population-based strategies include taxation, legislation, and […]
June 25th, 2012
Selections from Richard Lehman’s Literature Review: June 25th
Richard Lehman, BM, BCh, MRCGP
This week’s topics includes articles on industry regulation, the chronically comorbid, population risk for CV disease, and recombinant tissue plasminogen activator (rt-PA) for ischemic stroke.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?